Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
32,104,592
-
Shares change
-
-1,623,636
-
Total reported value, excl. options
-
$423,490,077
-
Value change
-
-$27,345,727
-
Number of buys
-
57
-
Number of sells
-
35
-
Price
-
$13.19
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q4 2018
As of 31 Dec 2018 Apellis Pharmaceuticals, Inc. - Common Stock (APLS) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,104,592 shares of stock of the company.
Largest 10 holders included Cormorant Asset Management, LP, BlackRock Inc., Hillhouse Capital Advisors, Ltd., Sectoral Asset Management Inc, Hillhouse Capital Management, Ltd., venBio Partners LLC, Vanguard Group Inc, VICTORY CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP.
This table shows 107 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.